CD44 as a marker for HIV infection

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 5, 435 71, 435 72, G01N 33533

Patent

active

051089041

ABSTRACT:
A method for discriminating between patients who are seropositive but asymptomatic for HIV infection and AIDS patients is disclosed wherein the fluorescence intensity from CD.sub.44.sup.+ T cells is measured. Intensity increases as AIDS progresses.

REFERENCES:
patent: 3826364 (1974-07-01), Bonner
patent: 4284412 (1981-08-01), Hansen
patent: 4452773 (1984-05-01), Molday
patent: 4520110 (1985-05-01), Stryer
patent: 4607007 (1986-08-01), Lanier et al.
patent: 4661913 (1987-04-01), Wu
patent: 4727020 (1988-02-01), Recktenwald
patent: 5002873 (1991-03-01), St. John et al.
Redfield et al., Sci. Amer., 259 70 (1988).
Weber et al., Sci. Amer., 259:80 (1988).
Leukocyte Typing IV, pp. 619-27 (1989).
Kohler et al., Nature 276 269 (1978).
Herzenberg et al., Sci. Amer. 234 108 (1976).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

CD44 as a marker for HIV infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CD44 as a marker for HIV infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CD44 as a marker for HIV infection will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1248828

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.